Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
$1.61
-0.05-3.01%
At close: Dec 15, 4:00 PM EST
$1.61
N/A
After Hours: 4:00 PM EST
Comments
Loading...
Akebia Therapeutics (AKBA) Stock Price, Quote, News & History
AKBANASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Akebia Therapeutics (AKBA) stock?
You can purchase shares of Akebia Therapeutics (NASDAQ:AKBA) through any online brokerage.
Who are Akebia Therapeutics (AKBA) competitors?
Other companies in Akebia Therapeutics’s space includes: Galectin Therapeutics Inc (NASDAQ:GALT), Monopar Therapeutics Inc (NASDAQ:MNPR), Immuneering Corp (NASDAQ:IMRX), Altimmune Inc (NASDAQ:ALT) and PepGen Inc (NASDAQ:PEPG).
What is the forecast, or price target, for Akebia Therapeutics (AKBA) stock?
Akebia Therapeutics has a consensus price target of $5.93.
What is the current price for Akebia Therapeutics (AKBA)?
The stock price for Akebia Therapeutics (NASDAQ: AKBA) is $1.61 last updated December 15, 2025 at 4:00 PM EST.
Does Akebia Therapeutics (AKBA) pay a dividend?
There are no upcoming dividends for Akebia Therapeutics.
When is Akebia Therapeutics (NASDAQ:AKBA) reporting earnings?
Akebia Therapeutics does not have any upcoming earnings scheduled.
Is Akebia Therapeutics (AKBA) going to split?
There is no upcoming split for Akebia Therapeutics.
What sector and industry does Akebia Therapeutics (AKBA) operate in?
Akebia Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
